A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

430

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Asthma
Interventions
DRUG

Symbicort TBH - Turbuhaler

Symbicort Single Inhaler Therapy ( Turbuhaler 160/4.5 microgram, 1 inhalation bid + as needed)

DRUG

beta-II-agonist, inhale steroid

Salbulin inh. 200-400 dosage 100 microgram (mcg)/dosage Salbutamol Sustained Release(SR)capsule 4 mg/8 mg Salbutol tablet (tb) 2 mg Salbutol forte syrup 2 mg/5 ml Ventolin tb, syrup, intravenous(IV),5mgx10 ampule(amp) Ventolin inhaler (inh) 200 dosage, 100 mcg/dosage Ventolin nebul 2.5 mg Volmax tb 4 mg/8 mg Vent-o-sal inh 100 mcg/200 dosage Combivent inh 100 mcg/dosage Combivent neb 2.5 mg/dosage Bricanyl tb 2.5 mg Bricanyl durules ret tb 5 mg Bricanyl syrup 30mg Bricanyl inhaler 0.25 mg/dosage, 400 dosage Bricanyl turbuhaler 0.5 mg/dosage, 200dosage

Trial Locations (15)

Unknown

Research Site, Ankara

Research Site, Antalya

Research Site, Bursa

Research Site, Denizli

Research Site, Diyarbakır

Research Site, Edirne

Research Site, Eski?ehir

Research Site, Istanbul

Research Site, Izmir

Research Site, Kocaeli

Research Site, Malatya

Research Site, Manisa

Research Site, Mersin

Research Site, Samsun

Research Site, Zonguldak

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY